Concepedia

Author

Victoria Rimkunas

Memorial Sloan Kettering Cancer CenterORCID

Also Known As

V. Rimkunas, Victoria M. Rimkunas, Victoria Rimkunas

177

Publications

1.7K

Citations

17

H-Index

45

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterIonis Pharmaceuticals (United States)Tufts UniversityMerrimack Pharmaceuticals (United States)Institute for Biomedicine
VR

About

Victoria Rimkunas is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

511

2

Cell Biology

4

4

488

3

Immunology

3

3

137

4

Engineering

2

2

79

5

Molecular Biology

2

2

79

Victoria Rimkunas

×

18

Publications

1.5K

Citations

15

H-Index

YearCitations

Survey of Tyrosine Kinase Signaling Reveals ROS Kinase Fusions in Human Cholangiocarcinoma

Ting-Lei Gu, Xiaxing Deng, Feizhou Huang,

PLoS ONE

2011

307

Analysis of Receptor Tyrosine Kinase ROS1-Positive Tumors in Non–Small Cell Lung Cancer: Identification of a FIG-ROS1 Fusion

Victoria Rimkunas, Katherine E. Crosby, Daiqiang Li,

Clinical Cancer Research

2012

291

H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

Jaya Julie Joshi, Heather Coffey, Erik Corcoran,

Cancer Research

2017

144

Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer

Manav Korpal, Xiaoling Puyang, Zhenhua J. Wu,

Nature Communications

2017

140

Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

Xiaoling Puyang, Craig Furman, Guo Zhu Zheng,

Cancer Discovery

2018

109

MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors

Jonathan B. Fitzgerald, Bryan W. Johnson, Jason Baum,

Molecular Cancer Therapeutics

2013

102

Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results

Timothy A. Yap, Elisa Fontana, Elizabeth K. Lee,

Nature Medicine

2023

94

Guiding ATR and PARP inhibitor combinations with chemogenomic screens

Michal Zimmermann, Cynthia Bernier, Beatrice Kaiser,

Cell Reports

2022

55

Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer

Adam J. Camblin, Emily A. Pace, Sharlene Adams,

Clinical Cancer Research

2018

53

TNF-α plays a role in hepatocyte apoptosis in Niemann-Pick type C liver disease

Victoria Rimkunas, Mark J. Graham, Rosanne M. Crooke,

Journal of Lipid Research

2008

41

Page 1